(A) Representative Western blot analysis of MKK4 abundance in young (Y, Pdl 11) and senescent (S, Pdl 51) IMR-90 fibroblasts, as well as in young (Pdl 24) and senescent (Pdl 54) WI-38 fibroblasts. β-actin was included as loading control. MKK4 signals from at least three Western blots were quantified by densitometry and normalized to β-actin signals. (B) MKK4 mRNA, as measured by RT-qPCR analysis of total RNA isolated from IMR-90 and WI-38 fibroblasts. (C) MKK4 protein stability was determined in young (Pdl 24) and senescent (Pdl 54) WI-38 cells that had been treated with cycloheximide (CHX, 50 μg/ml) and immunoblotting for MKK4 and GAPDH as a loading control. (D) Association of MKK4 mRNA (and GAPDH mRNA as a control) with cellular polysomes. After centrifugation of cytoplasmic components through linear 10–50% sucrose gradients, mRNA amounts in each fraction were measured by RT-qPCR and plotted as a percentage of the total mRNA in the sample. Arrow, direction of sedimentation; -, fractions lacking ribosome components; 40S and 60S, small and large ribosomal subunits, respectively; 80S, monosome; LMWP and HMWP, low- and high-molecular weight polysomes, respectively. (E) Schematic of the MKK4 mRNA, including the predicted target sites for miR-15b, miR-24, miR-25, and miR-141. (F) miR-15b, miR-24, miR-25, and miR-141 in young (Pdl 24) and senescent (Pdl 54) WI-38 cells were quantified by RT-qPCR analysis, normalized to 18S rRNA. As controls, U6 (which was unchanged between young and senescent cells) and let7a miRNA (which was elevated in senescent cells) were also measured. Data represent standard error of the mean (SEM) from 3 independent experiments; *, p<0.05, paired t test.